3,701
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Reduced death anxiety as a mediator of the relationship between acute subjective effects of psychedelics and improved subjective well-being

ORCID Icon, ORCID Icon, & ORCID Icon

References

  • Andersen, K. A., Carhart‐Harris, R., Nutt, D. J., & Erritzoe, D. (2021). Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies. Acta Psychiatrica Scandinavica, 143(2), 101–118. https://doi.org/10.1111/acps.13249
  • Arena, A. F., MacCann, C., Moreton, S. G., Menzies, R. E., & Tiliopoulos, N. (2022). Living authentically in the face of death: Predictors of autonomous motivation among individuals exposed to chronic mortality cues compared to a matched community sample. OMEGA-Journal of Death and Dying. https://doi.org/10.1177/00302228221074160
  • Arndt, J., Routledge, C., Cox, C. R., & Goldenberg, J. L. (2005). The worm at the core: A terror management perspective on the roots of psychological dysfunction. Applied and Preventive Psychology, 11(3), 191–213.
  • Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2015). Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford, England), 29(11), 1182–1190. https://doi.org/10.1177/0269881115609019
  • Becker, E. (1973). The denial of death. Free Press.
  • Carhart-Harris, R., Erritzoe, D., Haijen, E., Kaelen, M., & Watts, R. (2018). Psychedelics and connectedness. Psychopharmacology, 235(2), 547–550. https://doi.org/10.1007/s00213-017-4701-y
  • Chan, G., Sun, T., Lim, C., Yuen, W. S., Stjepanović, D., Rutherford, B., Hall, W., Johnson, B., & Leung, J. (2022). An age-period-cohort analysis of trends in psychedelic and ecstasy use in the Australian population. Addictive behaviors, 127, 107216.
  • Davis, A. K., Barrett, F. S., & Griffiths, R. R. (2020). Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Journal of Contextual Behavioral Science, 15, 39–45. https://doi.org/10.1016/j.jcbs.2019.11.004
  • Davis, A. K., Barrett, F. S., So, S., Gukasyan, N., Swift, T. C., & Griffiths, R. R. (2021). Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. Journal of Psychopharmacology (Oxford, England), 35(4), 437–446. https://doi.org/10.1177/0269881120967878
  • Davis, A. K., Clifton, J. M., Weaver, E. G., Hurwitz, E. S., Johnson, M. W., & Griffiths, R. R. (2020). Survey of entity encounter experiences occasioned by inhaled N, N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology (Oxford, England), 34(9), 1008–1020. https://doi.org/10.1177/0269881120916143
  • Diener, E. D., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985). The satisfaction with life scale. Journal of Personality Assessment, 49(1), 71–75.
  • Diener, E., Wirtz, D., Tov, W., Kim-Prieto, C., Choi, D-w., Oishi, S., & Biswas-Diener, R. (2010). New well-being measures: Short scales to assess flourishing and positive and negative feelings. Social Indicators Research, 97(2), 143–156.
  • Fauvel, B., Strika-Bruneau, L., & Piolino, P. (2021). Changes in self-rumination and self-compassion mediate the effect of psychedelic experiences on decreases in depression, anxiety, and stress. Psychology of Consciousness: Theory, Research, and Practice, https://doi.org/10.1037/cns0000283
  • Florian, V., & Mikulincer, M. (1998). Symbolic immortality and the management of the terror of death: the moderating role of attachment style. Journal of Personality and Social Psychology, 74(3), 725–734. https://doi.org/10.1037//0022-3514.74.3.725
  • Fortner, B. V., & Neimeyer, R. A. (1999). Death anxiety in older adults: A quantitative review. Death studies, 23(5), 387–411. https://doi.org/10.1080/074811899200920
  • Gandy, S. (2019). Psychedelics and potential benefits in “healthy normals”: A review of the literature. Journal of Psychedelic Studies, 3(3), 280–287. https://doi.org/10.1556/2054.2019.029
  • Grant, A. M., & Wade-Benzoni, K. A. (2009). The hot and cool of death awareness at work: Mortality cues, aging, and self-protective and prosocial motivations. Academy of Management Review, 34(4), 600–622.
  • Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W., & Jesse, R. (2019). Survey of subjective “God encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. Plos one, 14(4), e0214377. https://doi.org/10.1371/journal.pone.0214377
  • Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P., & Klinedinst, M. A. (2018). Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology (Oxford, England), 32(1), 49–69. https://doi.org/10.1177/0269881117731279
  • Griffiths, R. R., Richards, W. A., Johnson, M. W., McCann, U. D., & Jesse, R. (2008). Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology (Oxford, England), 22(6), 621–632. https://doi.org/10.1177/0269881108094300
  • Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283. https://doi.org/10.1007/s00213-006-0457-5
  • Grof, S. (1972). Varieties of transpersonal experiences: Observations from LSD psychotherapy. The Journal of Transpersonal Psychology, 4(1), 45.
  • Grof, S. (1973). Theoretical and empirical basis of transpersonal psychology and psychotherapy: Observations from LSD research. Journal of Transpersonal Psychology, 5(1), 15–53.
  • Hartogsohn, I. (2018). The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity. Frontiers in Neuroscience, 12, 129. https://doi.org/10.3389/fnins.2018.00129
  • Hayes, A. F. (2022). Introduction to mediation, moderation, and conditional process analysis: A regression-based approach (3rd ed.). The Guilford Press.
  • Iverach, L., Menzies, R. G., & Menzies, R. E. (2014). Death anxiety and its role in psychopathology: Reviewing the status of a transdiagnostic construct. Clinical psychology Review, 34(7), 580–593. https://doi.org/10.1016/j.cpr.2014.09.002
  • James, W. (1902/1985). The varieties of religious experience: A study in human nature. Harvard University Press.
  • Jennissen, S., Huber, J., Ehrenthal, J. C., Schauenburg, H., & Dinger, U. (2018). Association between insight and outcome of psychotherapy: systematic review and meta-analysis. The American Journal of Psychiatry, 175(10), 961–969. https://doi.org/10.1176/appi.ajp.2018.17080847
  • Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017). Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse, 43(1), 55–60. https://doi.org/10.3109/00952990.2016.1170135
  • Jungaberle, H., Thal, S., Zeuch, A., Rougemont-Bücking, A., von Heyden, M., Aicher, H., & Scheidegger, M. (2018). Positive psychology in the investigation of psychedelics and entactogens: A critical review. Neuropharmacology, 142, 179–199. https://doi.org/10.1016/j.neuropharm.2018.06.034
  • Livne, O., Shmulewitz, D., Walsh, C., & Hasin, D. S. (2022). Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP. Addiction (Abingdon, England), 117(12), 3099–3109. https://doi.org/10.1111/add.15987
  • Lo, C., Hales, S., Jung, J., Chiu, A., Panday, T., Rydall, A., Nissim, R., Malfitano, C., Petricone-Westwood, D., Zimmermann, C., & Rodin, G. (2014). Managing Cancer And Living Meaningfully (CALM): phase 2 trial of a brief individual psychotherapy for patients with advanced cancer. Palliative medicine, 28(3), 234–242.
  • May, R. (1967). The meaning of anxiety. (Revised ed.). W.W Norton.
  • Menzies, R. E., & Dar-Nimrod, I. (2017). Death anxiety and its relationship with obsessive-compulsive disorder. Journal of Abnormal Psychology, 126(4), 367–377. https://doi.org/10.1037/abn0000263
  • Menzies, R. E., Sharpe, L., & Dar-Nimrod, I. (2021). The effect of mortality salience on bodily scanning behaviors in anxiety-related disorders. Journal of Abnormal Psychology, 130(2), 141–151. https://doi.org/10.1037/abn0000577
  • Menzies, R. E., Sharpe, L., & Dar‐Nimrod, I. (2019). The relationship between death anxiety and severity of mental illnesses. British Journal of Clinical Psychology, 58(4), 452–467.
  • Menzies, R. E., Zuccala, M., Sharpe, L., & Dar-Nimrod, I. (2018). The effects of psychosocial interventions on death anxiety: A meta-analysis and systematic review of randomised controlled trials. Journal of Anxiety Disorders, 59, 64–73. https://doi.org/10.1016/j.janxdis.2018.09.004
  • Moreton, S. G., Burden-Hill, A., & Menzies, R. E. (2022). Reduced death anxiety and obsessive beliefs as mediators of the therapeutic effects of psychedelics on obsessive compulsive disorder symptomology. Clinical Psychologist, 1–16. https://doi.org/10.1080/13284207.2022.2086793
  • Moreton, S. G., Szalla, L., Menzies, R. E., & Arena, A. F. (2020). Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Psychopharmacology, 237(1), 21–32. https://doi.org/10.1007/s00213-019-05391-0
  • Nichols, D. E. (2016). Psychedelics. Pharmacological reviews, 68(2), 264–355. https://doi.org/10.1124/pr.115.011478
  • Noyes, R. Jr. (1980). Attitude change following near-death experiences. Psychiatry, 43(3), 234–242. https://doi.org/10.1080/00332747.1980.11024070
  • Olson, D. E. (2020). The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects. ACS Pharmacology & Translational Science, 4(2), 563–567.
  • Pahnke, W. N. (1969). The psychedelic mystical experience in the human encounter with death. Harvard Theological Review, 62(1), 1–21. https://doi.org/10.1017/S0017816000027577
  • Pahnke, W. N., Kurland, A. A., Unger, S., Savage, C., & Grof, S. (1970). The experimental use of psychedelic (LSD) psychotherapy. JAMA, 212(11), 1856–1863. https://doi.org/10.1001/jama.1970.03170240060010
  • Pavot, W., & Diener, E. (2009). Review of the satisfaction with life scale. In Assessing well-being (pp. 101–117). Springer.
  • Peill, J. M., Trinci, K. E., Kettner, H., Mertens, L. J., Roseman, L., Timmermann, C., Rosas, F. E., Lyons, T., & Carhart-Harris, R. L. (2022). Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. Journal of Psychopharmacology, 36(1), 31–45.
  • Pyszczynski, T., Greenberg, J., Solomon, S., & Hamilton, J. (1990). A terror management analysis of self-awareness and anxiety: The hierarchy of terror. Anxiety Research, 2(3), 177–195.
  • Reiche, S., Hermle, L., Gutwinski, S., Jungaberle, H., Gasser, P., & Majić, T. (2018). Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 81, 1–10. https://doi.org/10.1016/j.pnpbp.2017.09.012
  • Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2017). Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology, 8, 974. https://doi.org/10.3389/fphar.2017.00974
  • Ross, S. (2018). Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress. International Review of Psychiatry, 30(4), 317–330. https://doi.org/10.1080/09540261.2018.1482261
  • Routledge, C., & Juhl, J. (2010). When death thoughts lead to death fears: Mortality salience increases death anxiety for individuals who lack meaning in life. Cognition and Emotion, 24(5), 848–854.
  • Ryan, R. M., & Deci, E. L. (2001). On happiness and human potentials: A review of research on hedonic and eudaimonic well-being. Annual review of Psychology, 52(1), 141–166.
  • Ryff, C. D. (2014). Psychological well-being revisited: Advances in the science and practice of eudaimonia. Psychotherapy and Psychosomatics, 83(1), 10–28. https://doi.org/10.1159/000353263
  • Strachan, E., Schimel, J., Arndt, J., Williams, T., Solomon, S., Pyszczynski, T., & Greenberg, J. (2007). Terror mismanagement: Evidence that mortality salience exacerbates phobic and compulsive behaviors. Personality & Social Psychology Bulletin, 33(8), 1137–1151. https://doi.org/10.1177/0146167207303018
  • Sweeney, M. M., Nayak, S., Hurwitz, E. S., Mitchell, L. N., Swift, T. C., & Griffiths, R. R. (2022). Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying. PloS one, 17(8), e0271926. https://doi.org/10.1371/journal.pone.0271926
  • Timmermann, C., Kettner, H., Letheby, C., Roseman, L., Rosas, F. E., & Carhart-Harris, R. L. (2021). Psychedelics alter metaphysical beliefs. Scientific reports, 11(1), 1–13.
  • Timmermann, C., Roseman, L., Williams, L., Erritzoe, D., Martial, C., Cassol, H., Laureys, S., Nutt, D., & Carhart-Harris, R. (2018). DMT models the near-death experience. Frontiers in Psychology, 9, 1424. https://doi.org/10.3389/fpsyg.2018.01424
  • Tomer, A. (1992). Death anxiety in adult life—theoretical perspectives. Death studies, 16(6), 475–506. https://doi.org/10.1080/07481189208252594
  • Vassar, M. (2008). A note on the score reliability for the Satisfaction With Life Scale: An RG study. Social Indicators Research, 86(1), 47–57.
  • Wong, P. T. (2007). Meaning management theory and death acceptance. In Existential and spiritual issues in death attitudes (pp. 91–114). Psychology Press.
  • Wong, P. T., Reker, G. T., & Gesser, G. (1994). Death attitude profile-revised: A multidimensional measure of attitudes toward death. Death anxiety Handbook: Research, Instrumentation, and Application, 121, 121–148.
  • Yaden, D. B., & Griffiths, R. R. (2021). The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS pharmacology & Translational Science, 4(2), 568–572. https://doi.org/10.1021/acsptsci.0c00194
  • Yalom, I. D. (1980). Existential psychotherapy (Vol. 1). Basic Books New York.
  • Yalom, I. D. (2008). Staring at the sun: Overcoming the terror of death. The Humanistic Psychologist, 36(3–4), 283–297. https://doi.org/10.1080/08873260802350006
  • Zuccala, M., Menzies, R. E., Hunt, C. J., & Abbott, M. J. (2022). A systematic review of the psychometric properties of death anxiety self-report measures. Death studies, 46(2), 257–279. https://doi.org/10.1080/07481187.2019.1699203